Pharmaresearch Product Rises 7.76% Amid Botox (Botulinum Toxin) Theme Uptrend

On the 18th, the Botox (Botulinum toxin) theme showed strength, rising 3.05% compared to the previous day, while PharmaResearch Product, a related stock attracting attention, surged 7.76% from the previous day. PharmaResearch Product is known as a regenerative bio pharmaceutical company.

[Graph] Major stock price changes in the Botox (Botulinum toxin) theme



According to preliminary data compiled at 11:06, foreign investors have purchased 44,700 shares of PharmaResearch Product, indicating a large net buying by foreigners.

[Table] Net buying and selling volume by foreigners and institutions (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, PharmaResearch Product ranked 3rd out of 10 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as PharmaResearch Product having relatively high investment attractiveness compared to other stocks in the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme


※ The quant financial score is the result of the robo algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.